Cite

    Cojutti, P. et al. (2018). Co‐administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed‐released tablets in adult patients with haematological malignancies. British journal of clinical pharmacology. pp. 2544-2550. [Online].